These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

104 related items for PubMed ID: 3857117

  • 1. Identification of endogenous inhibitory growth factors from a human colon carcinoma cell line.
    Levine AE, McRae LJ, Hamilton DA, Brattain DE, Yeoman LC, Brattain MG.
    Cancer Res; 1985 May; 45(5):2248-54. PubMed ID: 3857117
    [Abstract] [Full Text] [Related]

  • 2. Isolation of tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
    Iwata KK, Fryling CM, Knott WB, Todaro GJ.
    Cancer Res; 1985 Jun; 45(6):2689-94. PubMed ID: 3857121
    [Abstract] [Full Text] [Related]

  • 3. Two distinct tumor cell growth-inhibiting factors from a human rhabdomyosarcoma cell line.
    Fryling CM, Iwata KK, Johnson PA, Knott WB, Todaro GJ.
    Cancer Res; 1985 Jun; 45(6):2695-9. PubMed ID: 2580626
    [Abstract] [Full Text] [Related]

  • 4. Multiplicity of transforming growth factors in human malignant effusions.
    Seo MK, Lynch KE, Podolsky DK.
    Cancer Res; 1988 Apr 01; 48(7):1792-7. PubMed ID: 2894891
    [Abstract] [Full Text] [Related]

  • 5. Characterization of the inhibitory effects of transforming growth factor-beta on a human colon carcinoma cell line.
    Hoosein NM, Brattain DE, McKnight MK, Levine AE, Brattain MG.
    Cancer Res; 1987 Jun 01; 47(11):2950-4. PubMed ID: 3471320
    [Abstract] [Full Text] [Related]

  • 6. Diverse cellular responses elicited from human colon carcinoma cells by transforming growth factor-beta.
    Chakrabarty S, Jan Y, Brattain MG, Tobon A, Varani J.
    Cancer Res; 1989 Apr 15; 49(8):2112-7. PubMed ID: 2539253
    [Abstract] [Full Text] [Related]

  • 7. Effects of N,N-dimethylformamide and extracellular matrix on transforming growth factor-beta binding to a human colon carcinoma cell line.
    Levine AE, Black B, Brattain MG.
    J Cell Physiol; 1989 Mar 15; 138(3):459-66. PubMed ID: 2925796
    [Abstract] [Full Text] [Related]

  • 8. Presence of transforming growth factors in human breast cancer cells.
    Salomon DS, Zwiebel JA, Bano M, Losonczy I, Fehnel P, Kidwell WR.
    Cancer Res; 1984 Sep 15; 44(9):4069-77. PubMed ID: 6331663
    [Abstract] [Full Text] [Related]

  • 9. Characterization of autostimulatory and transforming growth factors from human melanoma cells.
    Richmond A, Lawson DH, Nixon DW, Chawla RK.
    Cancer Res; 1985 Dec 15; 45(12 Pt 1):6390-4. PubMed ID: 3864531
    [Abstract] [Full Text] [Related]

  • 10. Epithelial tissue-derived growth factor-like polypeptides.
    Halper J, Moses HL.
    Cancer Res; 1983 May 15; 43(5):1972-9. PubMed ID: 6572559
    [Abstract] [Full Text] [Related]

  • 11. Anchorage-independent growth-conferring factor production by rat mammary tumor cells.
    Zwiebel JA, Davis MR, Kohn E, Salomon DS, Kidwell WR.
    Cancer Res; 1982 Dec 15; 42(12):5117-25. PubMed ID: 6291748
    [Abstract] [Full Text] [Related]

  • 12. Purification of melanoma growth stimulatory activity.
    Richmond A, Thomas HG.
    J Cell Physiol; 1986 Dec 15; 129(3):375-84. PubMed ID: 3465735
    [Abstract] [Full Text] [Related]

  • 13. Characterization of transforming growth factor-beta-resistant subclones isolated from a transforming growth factor-beta-sensitive human colon carcinoma cell line.
    Mulder KM, Ramey MK, Hoosein NM, Levine AE, Hinshaw XH, Brattain DE, Brattain MG.
    Cancer Res; 1988 Dec 15; 48(24 Pt 1):7120-5. PubMed ID: 3191488
    [Abstract] [Full Text] [Related]

  • 14. Isolation and partial purification of a new class of transforming growth factors from an avian sarcoma virus-transformed rat cell line.
    Hirai R, Yamaoka K, Mitsui H.
    Cancer Res; 1983 Dec 15; 43(12 Pt 1):5742-6. PubMed ID: 6315215
    [Abstract] [Full Text] [Related]

  • 15. Transforming growth factors in solid human malignant neoplasms.
    Nickell KA, Halper J, Moses HL.
    Cancer Res; 1983 May 15; 43(5):1966-71. PubMed ID: 6299535
    [Abstract] [Full Text] [Related]

  • 16. Latent transformed growth-inhibiting factor in human malignant effusions.
    Podolsky DK, Pleskow DK, Jafari H.
    Cancer Res; 1988 Jan 15; 48(2):418-24. PubMed ID: 3257164
    [Abstract] [Full Text] [Related]

  • 17. Growth factor-independent proliferation of rat mammary carcinoma cells by autocrine secretion of neu-differentiation factor/heregulin and transforming growth factor-alpha.
    Ethier SP, Langton BC, Dilts CA.
    Mol Carcinog; 1996 Feb 15; 15(2):134-43. PubMed ID: 8599580
    [Abstract] [Full Text] [Related]

  • 18. Colon carcinoma cells switch their response to transforming growth factor beta 1 with tumor progression.
    Hsu S, Huang F, Hafez M, Winawer S, Friedman E.
    Cell Growth Differ; 1994 Mar 15; 5(3):267-75. PubMed ID: 8018559
    [Abstract] [Full Text] [Related]

  • 19. Contextual effects of transforming growth factor beta on the tumorigenicity of human colon carcinoma cells.
    Ye SC, Foster JM, Li W, Liang J, Zborowska E, Venkateswarlu S, Gong J, Brattain MG, Willson JK.
    Cancer Res; 1999 Sep 15; 59(18):4725-31. PubMed ID: 10493532
    [Abstract] [Full Text] [Related]

  • 20. Autocrine transforming growth factor-beta 1 and beta 2 expression is increased by cell crowding and quiescence in colon carcinoma cells.
    Sun L, Wu S, Coleman K, Fields KC, Humphrey LE, Brattain MG.
    Exp Cell Res; 1994 Sep 15; 214(1):215-24. PubMed ID: 8082724
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.